Intuitive Surgical (ISRG) Net Income towards Common Stockholders (2009 - 2026)

Intuitive Surgical's (ISRG) quarterly Net Income towards Common Stockholders came in at $823.2 million in Q2 2026, up 23.94% year-on-year from $664.2 million in Q2 2025, and little changed quarter-over-quarter from $826.0 million in Q1 2026.

Intuitive Surgical (ISRG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Intuitive Surgical's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $823.2 million for Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 23.94% year-over-year to $823.2 million in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 20.23% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 23.06% from the prior year.
  • Net Income towards Common Stockholders was little changed at $823.2 million in Q2 2026 per ISRG's latest filing, from $826.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $826.0 million in Q1 2026 and bottomed at $313.6 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is $559.0 million (2024), against an average of $556.9 million.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 40.04% in 2022 and jumped 81.38% in 2023, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $336.7 million in 2022, then soared by 81.38% to $610.7 million in 2023, then grew by 12.66% to $688.0 million in 2024, then advanced by 16.21% to $799.5 million in 2025, then grew by 2.96% to $823.2 million in 2026.
  • Per Business Quant, the three latest ISRG Net Income towards Common Stockholders figures stand at $823.2 million (Q2 2026), $826.0 million (Q1 2026), and $799.5 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -274.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn 22.13 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn 112.77 Mn
10 Baxter International 12.00 Bn 9.98 Bn 891.00 Mn 2.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 823.20 Mn
Mar 31, 2026 826.00 Mn
Dec 31, 2025 799.50 Mn
Sep 30, 2025 709.20 Mn
Jun 30, 2025 664.20 Mn
Mar 31, 2025 703.70 Mn
Dec 31, 2024 688.00 Mn
Sep 30, 2024 570.60 Mn
Jun 30, 2024 531.50 Mn
Mar 31, 2024 547.40 Mn
Dec 31, 2023 610.70 Mn
Sep 30, 2023 419.80 Mn
Jun 30, 2023 426.00 Mn
Mar 31, 2023 360.80 Mn
Dec 31, 2022 336.70 Mn
Sep 30, 2022 324.70 Mn
Jun 30, 2022 313.60 Mn
Mar 31, 2022 369.40 Mn
Dec 31, 2021 382.70 Mn
Sep 30, 2021 387.20 Mn